Novo Nordisk’s Wegovy and copyright, equally driven by semaglutide, have revolutionized obesity therapy via unprecedented weight loss outcomes.This led Novo Nordisk to carry out even further investigate into higher dosages of semaglutide specifically for weight management.The subsequent desk lists the form, dosage, and frequency of administration